Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01687166 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
A NA study of Paroxysmal Atrial Fibrillation (PAF), sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 398
- Enrollment target
- 20
- Study locations
NCT01687166 is a NA study of Paroxysmal Atrial Fibrillation (PAF) that has completed, run by Boston Scientific Corporation. The registered enrollment target is 398 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT01687166, a NA study of Paroxysmal Atrial Fibrillation (PAF), has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 398 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to establish the safety and effectiveness of the Blazer Open-Irrigated radiofrequency ablation catheter for the treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.
Conditions Studied
Interventions
- DEVICE Blazer Open-Irrigated Ablation Catheter (Boston Scientific)
- DEVICE FDA Approved Open-Irrigated Ablation Catheter
Study Locations (20)
Florida
- St. Vincent's Medical Center - Jacksonville
- Baptist Hospital - Pensacola
- Tampa General Hospital - Tampa
New York
- New York University - New York
- Mt. Sinai Medical Center - New York
- Strong Memorial Hospital of the University of Rochester - Rochester
Alabama
- University of Alabama at Birmingham - Birmingham
- Hunstville Hospital - Huntsville
California
- Sequoia Hospital - Redwood City
- University of California, San Francisco - San Francisco
Georgia
- Emory University Hospital - Atlanta
- Georgia Health Sciences University - Augusta
Michigan
- University of Michigan - Ann Arbor
- William Beaumont Hospital - Royal Oak
Connecticut
- Yale University - New Haven
Maryland
- Union Memorial Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01687166
The ClinicalTrials.gov registry entry for NCT01687166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 398 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation (PAF) appearing as the primary indexed condition, and to 2 interventions - of which Blazer Open-Irrigated Ablation Catheter (Boston Scientific) is the first listed.
NCT01687166 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, New York, Alabama.
Frequently Asked Questions
What is clinical trial NCT01687166 about?
NCT01687166 is a clinical study titled "Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation". The purpose of this study is to establish the safety and effectiveness of the Blazer Open-Irrigated radiofrequency ablation catheter for the treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.
What is the current status of trial NCT01687166?
This trial is currently completed. It is a NA study. The enrollment target is 398 participants. The study started on 2012-10. Estimated completion is 2016-10.
What conditions does trial NCT01687166 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation (PAF).
What interventions are being tested in trial NCT01687166?
The interventions under investigation include: Blazer Open-Irrigated Ablation Catheter (Boston Scientific) (DEVICE), FDA Approved Open-Irrigated Ablation Catheter (DEVICE).
Who is sponsoring clinical trial NCT01687166?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01687166 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation (PAF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
COMPLETED · NA
-
Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.